Catherine Chang

2.1k total citations
19 papers, 513 citations indexed

About

Catherine Chang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Catherine Chang has authored 19 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Catherine Chang's work include Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Catherine Chang is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Catherine Chang collaborates with scholars based in Australia, United Kingdom and United States. Catherine Chang's co-authors include Gemma L. Kelly, Andreas Strasser, Fan Jiang, Gregory J. Dusting, Hitesh Peshavariya, Marco J. Herold, Grant Dewson, Guei‐Sheung Liu, Elsa C. Chan and Guillaume Lessène and has published in prestigious journals such as Genes & Development, Blood and Cancer Cell.

In The Last Decade

Catherine Chang

19 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Chang Australia 15 275 145 139 78 60 19 513
Sarah T. Diepstraten Australia 10 439 1.6× 118 0.8× 159 1.1× 102 1.3× 49 0.8× 18 651
Huei-Mei Huang Taiwan 13 312 1.1× 165 1.1× 131 0.9× 53 0.7× 23 0.4× 23 606
Yiqing Zhao China 16 628 2.3× 173 1.2× 196 1.4× 125 1.6× 34 0.6× 37 901
Jui Dutta United States 8 461 1.7× 172 1.2× 183 1.3× 215 2.8× 47 0.8× 14 752
Jennifer L. Carroll United States 13 281 1.0× 97 0.7× 100 0.7× 84 1.1× 74 1.2× 19 593
Bu‐Nam Jeon South Korea 14 453 1.6× 111 0.8× 125 0.9× 125 1.6× 32 0.5× 27 639
Aida S. Hansen Denmark 10 509 1.9× 172 1.2× 247 1.8× 184 2.4× 84 1.4× 21 903
Yuen Yuen Hong Kong 14 253 0.9× 209 1.4× 166 1.2× 137 1.8× 47 0.8× 16 671
Jie Han United States 15 527 1.9× 176 1.2× 142 1.0× 119 1.5× 46 0.8× 24 767
Janey N. Parsons United States 9 384 1.4× 179 1.2× 126 0.9× 73 0.9× 39 0.7× 10 691

Countries citing papers authored by Catherine Chang

Since Specialization
Citations

This map shows the geographic impact of Catherine Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Chang more than expected).

Fields of papers citing papers by Catherine Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Chang. The network helps show where Catherine Chang may publish in the future.

Co-authorship network of co-authors of Catherine Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Chang. A scholar is included among the top collaborators of Catherine Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Chang. Catherine Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Diepstraten, Sarah T., Yuan Yin, Catherine Chang, et al.. (2024). Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers. Cancer Cell. 42(5). 850–868.e9. 25 indexed citations
2.
Aubrey, Brandon J., Catherine Chang, Zilu Wang, et al.. (2023). Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses. Cell Death and Differentiation. 31(2). 150–158. 5 indexed citations
3.
Diepstraten, Sarah T., et al.. (2023). BCL-W makes only minor contributions to MYC-driven lymphoma development. Oncogene. 42(37). 2776–2781. 1 indexed citations
4.
Wang, Zilu, Huimin Hu, Kelly L. Rogers, et al.. (2023). The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell Death and Differentiation. 30(4). 1033–1046. 23 indexed citations
5.
Lieschke, Elizabeth, Zilu Wang, Catherine Chang, et al.. (2022). Flow cytometric single cell-based assay to simultaneously detect cell death, cell cycling, DNA content and cell senescence. Cell Death and Differentiation. 29(5). 1004–1012. 10 indexed citations
6.
Diepstraten, Sarah T., Catherine Chang, Lin Tai, et al.. (2020). BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines. Blood Advances. 4(2). 356–366. 16 indexed citations
7.
Tierney, Rosemary J., Catherine Chang, Olga Kondrashova, et al.. (2020). BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma.. PubMed. 4(19). 4775–4787. 15 indexed citations
8.
Fitzsimmons, Leah, Catherine Chang, Laura C.A. Galbraith, et al.. (2019). EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins. Cell Death and Differentiation. 27(5). 1554–1568. 47 indexed citations
9.
Brennan, Margs S., Catherine Chang, Lin Tai, et al.. (2018). Humanized Mcl-1 mice enable accurate preclinical evaluation of MCL-1 inhibitors destined for clinical use. Blood. 132(15). 1573–1583. 66 indexed citations
10.
Aubrey, Brandon J., Ana Janic, Yunshun Chen, et al.. (2018). Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor development. Genes & Development. 32(21-22). 1420–1429. 35 indexed citations
11.
Fitzsimmons, Leah, Wenbin Wei, Catherine Chang, et al.. (2017). Coordinated repression of BIM and PUMA by Epstein–Barr virus latent genes maintains the survival of Burkitt lymphoma cells. Cell Death and Differentiation. 25(2). 241–254. 18 indexed citations
12.
Liu, Rui, Nícolas C. Hoch, Catherine Chang, et al.. (2017). ASCIZ/ATMIN is dispensable for ATM signaling in response to replication stress. DNA repair. 57. 29–34. 8 indexed citations
13.
Vikstrom, Ingela B., Anne Slomp, Emma M. Carrington, et al.. (2016). MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL. Cell Death and Disease. 7(8). e2345–e2345. 46 indexed citations
14.
Peshavariya, Hitesh, Guei‐Sheung Liu, Catherine Chang, et al.. (2014). Prostacyclin Signaling Boosts NADPH Oxidase 4 in the Endothelium Promoting Cytoprotection and Angiogenesis. Antioxidants and Redox Signaling. 20(17). 2710–2725. 38 indexed citations
15.
Liu, Guei‐Sheung, Hitesh Peshavariya, Masayoshi Higuchi, et al.. (2012). Microphthalmia-associated transcription factor modulates expression of NADPH oxidase type 4: A negative regulator of melanogenesis. Free Radical Biology and Medicine. 52(9). 1835–1843. 33 indexed citations
16.
Jiang, Fan, Catherine Chang, & Gregory J. Dusting. (2010). Cytoprotection by Natural and Synthetic Polyphenols in the Heart: Novel Mechanisms and Perspectives. Current Pharmaceutical Design. 16(37). 4103–4112. 14 indexed citations
17.
Peshavariya, Hitesh, Fan Jiang, Caroline J. Taylor, et al.. (2009). Translation-Linked mRNA Destabilization Accompanying Serum-Induced Nox4 Expression in Human Endothelial Cells. Antioxidants and Redox Signaling. 11(10). 2399–2408. 45 indexed citations
18.
Tegley, Christopher M., Vellarkad N. Viswanadhan, Kaustav Biswas, et al.. (2008). Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation. Bioorganic & Medicinal Chemistry Letters. 18(14). 3925–3928. 39 indexed citations
19.
Frohn, Mike, Han Xu, Xiaoming Zou, et al.. (2007). New ‘chemical probes’ to examine the role of the hFPRL1 (or ALXR) receptor in inflammation. Bioorganic & Medicinal Chemistry Letters. 17(23). 6633–6637. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah T. Diepstraten Breakdown of academic impact, for papers by Huei-Mei Huang Breakdown of academic impact, for papers by Yiqing Zhao Breakdown of academic impact, for papers by Jui Dutta Breakdown of academic impact, for papers by Jennifer L. Carroll Breakdown of academic impact, for papers by Bu‐Nam Jeon Breakdown of academic impact, for papers by Aida S. Hansen Breakdown of academic impact, for papers by Yuen Yuen Breakdown of academic impact, for papers by Jie Han Breakdown of academic impact, for papers by Janey N. Parsons
Rankless by CCL
2026